Ameriprise Financial Inc Anavex Life Sciences Corp. Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Ameriprise Financial Inc holds 66,810 shares of AVXL stock, worth $569,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,810

Previous 63,567 5.1%

Holding current value

$569,221

Previous $361,000 98.61%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.11 - $12.56 $16,571 - $40,732	3,243 Added 5.1%	66,810 $717,000
Q3 2024 Nov 14, 2024	BUY	$4.11 - $7.04 $349 - $598	85 Added 0.13%	63,567 $361,000
Q2 2024 Aug 14, 2024	SELL	$3.39 - $5.02 $2,474 - $3,664	-730 Reduced 1.14%	63,482 $267,000
Q1 2024 May 15, 2024	BUY	$4.55 - $6.75 $43,498 - $64,530	9,560 Added 17.49%	64,212 $326,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $92,116 - $181,856	18,277 Added 50.25%	54,652 $508,000
Q3 2023 Nov 14, 2023	BUY	$6.55 - $9.37 $19,086 - $27,304	2,914 Added 8.71%	36,375 $238,000
Q2 2023 Aug 14, 2023	SELL	$7.66 - $9.5 $114 - $142	-15 Reduced 0.04%	33,461 $272,000
Q1 2023 May 15, 2023	SELL	$8.32 - $11.75 $1,447 - $2,044	-174 Reduced 0.52%	33,476 $286,000
Q4 2022 Feb 14, 2023	BUY	$7.65 - $14.43 $106,296 - $200,504	13,895 Added 70.34%	33,650 $311,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $20,915 - $30,221	2,350 Added 13.5%	19,755 $203,000
Q2 2022 Aug 15, 2022	BUY	$7.31 - $12.84 $2,193 - $3,852	300 Added 1.75%	17,405 $174,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $57,076 - $103,663	-5,860 Reduced 25.52%	17,105 $211,000
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $219,440 - $303,030	-13,000 Reduced 36.15%	22,965 $398,000
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $440,599 - $674,521	-26,195 Reduced 42.14%	35,965 $645,000
Q2 2021 Aug 16, 2021	SELL	$10.16 - $28.86 $314,604 - $893,649	-30,965 Reduced 33.25%	62,160 $1.42 Million
Q1 2021 May 17, 2021	BUY	$5.17 - $16.13 $127,828 - $398,814	24,725 Added 36.15%	93,125 $1.39 Million
Q4 2020 Feb 12, 2021	BUY	$4.01 - $7.58 $142,936 - $270,189	35,645 Added 108.82%	68,400 $369,000
Q3 2020 Nov 16, 2020	BUY	$3.8 - $5.0 $67,203 - $88,425	17,685 Added 117.35%	32,755 $149,000
Q2 2020 Aug 14, 2020	SELL	$2.62 - $5.2 $4,545 - $9,022	-1,735 Reduced 10.32%	15,070 $74,000
Q1 2020 May 15, 2020	SELL	$2.38 - $5.81 $9,996 - $24,402	-4,200 Reduced 20.0%	16,805 $53,000
Q4 2019 Feb 14, 2020	BUY	$2.31 - $3.14 $11,561 - $15,715	5,005 Added 31.28%	21,005 $54,000
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.9 $35,520 - $62,400	16,000 New	16,000 $19,000

Others Institutions Holding AVXL

# of Institutions

182

Shares Held

28.9M

Call Options Held

749K

Put Options Held

825K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $664M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Anavex Life Sciences Corp. Transaction History